1. Simulating the Real World of Antihyperglycaemic Therapies in Type 2 Diabetes

   • Amanda I. Adler

   Introduction 07 February 2013 Pages: 1 - 3

2. A Model of Long-term Metabolic Progression of Type 2 Diabetes Mellitus for Evaluating Treatment Strategies

   • Adrian Bagust
   • Marc Evans
   • Murray Stewart

   Original Research Article 07 February 2013 Pages: 5 - 19

3. Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK

   • Sophie Beale
   • Adrian Bagust
   • Lisa Hulme

   Original Research Article 07 February 2013 Pages: 21 - 34

4. Cost-effectiveness of Rosiglitazone Oral Combination for the Treatment of Type 2 Diabetes in Germany

   • Arran T. Shearer
   • Adrian Bagust
   • Anita Goertz

   Original Research Article 07 February 2013 Pages: 35 - 48

5. Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain

   • Arran T. Shearer
   • Adrian Bagust
   • Gonzalo París

   Original Research Article 07 February 2013 Pages: 49 - 59